Navigation Links
Some minorities believe they are less likely to get cancer compared to whites, Moffitt study shows
Date:4/16/2013

Researchers at Moffitt Cancer Center and colleagues analyzed national data to investigate the differences in cancer prevention beliefs by race and ethnicity. They found that minorities, including blacks, Asians and Hispanics, have differing beliefs about cancer prevention and feel they are less likely to get cancer than did whites. The researchers concluded that more culturally relevant information about cancer prevention and risk needs to reach minority populations.

Their study appears online in the American Journal of Health Promotion.

"The purpose of our study was to determine if there were racial and ethnic differences in the general beliefs and perceptions about cancer and cancer prevention," said study lead author Jenna L. Davis, M.P.H, research coordinator for Moffitt's Health Outcomes and Behavior Program. "We used the Health Belief Model, a theory that explains an individual's process for engaging in a certain health behavior or not based on their personal beliefs or perceptions."

The researchers assessed participants' beliefs regarding their risk of getting cancer, severity of cancer, and the benefit of detecting cancer early. They were also asked about their ability to prevent cancer and their understanding of screening and detection.

"We found that blacks, Asians and Hispanics were all more likely to believe that they had a lower chance of getting cancer than did whites," said study senior author B. Lee Green, Ph.D., senior member of the Health Outcomes and Behavior Program at Moffitt. "This is significant and surprising because statistics show that racial and ethnic minorities, especially blacks, have higher cancer mortality, incidence and prevalence rates than whites and also differ from whites in engaging in preventive behaviors."

Hispanics were also less likely than whites and blacks to believe that they could lower their chances of getting cancer. Regardless of race or ethnicity, participants felt that it was difficult to know which cancer prevention recommendations to follow.

"There is a need for consistent cancer prevention messages and screening recommendations, as well as opportunities to increase education on cancer prevention among all populations," Green said. "These efforts will make individuals feel more empowered to participate in cancer preventive behaviors."

Given the racial and ethnic disparity in beliefs about cancer prevention when compared to whites, the researchers concluded that their study should encourage researchers and health practitioners to design cancer education and prevention interventions that are culturally relevant for racial and ethnic minorities to better educate them about cancer susceptibility and risk.

"Research on how risk information is communicated to various racial and ethnic groups, and how these groups react to cancer risk messages, is also needed," Davis concluded.


'/>"/>

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Related medicine news :

1. Highlights on women, minorities and persons with disabilities in science and engineering
2. Minorities most likely to have aggressive tumors, less likely to get radiation
3. Nearly half of kidney recipients in live donor transplant chains are minorities
4. Minorities Less Likely to Use Hospice Care: Study
5. Minorities, Medicare Recipients Less Likely to Get Antidepressants
6. Oral Herpes Spread Through Kissing? polyDNA’s Monthly Survey Shows Segment of Public Believes Kissing with Fever Blisters Won’t Transmit the Virus
7. The aging brain is more malleable than previously believed
8. Benefits of HIV drugs rise -- but less than previously believed, Penn study shows
9. Schizophrenia in Movies: Dont Believe Everything You See
10. Differences in staging and treatment likely to be behind UKs low bowel cancer survival
11. Kids With Autism May Be Less Likely to Imitate Silly Behavior
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... As part of their 2015 end of year ... Table Foundation (MDRTF), has gifted $10,000 to University of Chicago to support ovarian cancer ... Cundiff. , “We are honored to support a promising young investigator from Dr. Lengyel’s ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... World Molecular Imaging Congress (WMIC), will be held in New York City, NY ... “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals a ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Early this week, ... and raise awareness of Nestlé KITKAT as the first global confectionery brand sourced from ... cocoa farmers and the quality of their product, through activities that focus on better ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
(Date:2/10/2016)... Walton Beach, Florida (PRWEB) , ... February 10, ... ... the innovative weather-forecasting company is unveiling its revolutionary new 2.0 version at the ... platform, MetLoop has “put the power of the world's most advanced weather technology ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... fourth quarter and full year ended December 31, 2015. ... was a transformational year for Vanda with the continued ... market approval of HETLIOZ for Non-24," said Mihael H. ... Fanapt to our U.S. product portfolio builds on this ...
(Date:2/10/2016)... , February 10, 2016 ... Analyzers (Liquid & Gas), and Spectroscopy Market by Industry (Oil ... Beverage, Pulp & Paper, Metal & Mining, and Others), ... MarketsandMarkets, the global market is expected to grow to ... of 8.6% between 2015 and 2020. Browse ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
Breaking Medicine Technology: